WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Wraps Up 2025 Drug Negotiation: Dual Catalogs Debut, Innovative Drug Cut... From October 30 to November 3, China's 2025 National Reimbursement Drug Negotiations officially concluded after five days of talks — marking the first time that the coun...
(11/5/2025)

China Wraps Up 2025 Drug Negotiation: Dual Cat... (11/5/2025)

MNCs Retreat as China Cancels Dozens of Brande... (11/5/2025)

Bloomberg: China Has Another Trade Weapon Wait... (11/5/2025)

China's Biotech Deal Boom Tests Ethical Bounda... (10/31/2025)

China Pushes Ethical Limits in Global Biotech ... (10/29/2025)

Understanding China's Longevity Market: Indust... (10/22/2025)

ESMO 2025 Highlights China's Strategic Leap in... (10/21/2025)

Novo vs. KBP: Fraud or Due Diligence Slipup? (... (10/17/2025)

First Drug Patent Term Extension Granted In Ch... (10/13/2025)

U.S. Senate Approves Revised China Biotech Com... (10/13/2025)

China's Innovative Drug Sector Secures Over CN... (10/13/2025)

Challenges and Opportunities in Oncology Drug ... (9/23/2025)

Recent Executive Moves (11/7/2025) NMPA Pilots Streamlined Review Pathway f... (11/7/2025) UniXell Secures CNY 100M in Series A+ F... (11/7/2025) Vigonvita Life Sciences Debuts on HKSE (11/7/2025) Lepu to Present Promising Phase II Data ... (11/7/2025) CARsgen Reports Positive Results for All... (11/7/2025) Sanofi's Cablivi Wins Approval in China ... (11/7/2025) Correctseq Reports World's First Gene-Ed... (11/7/2025) Innorna Reportedly Targets $200M Hong Ko... (11/6/2025) Clariant Completes Expansion of Pharma E... (11/6/2025) AstraZeneca Adds CNY 990M Investment to ... (11/6/2025) Lilly Expands AI Collaboration with Xtal... (11/6/2025) Ivacta Raises CNY 100M+ in Angel Round L... (11/6/2025) China Grants Conditional Approval for AC... (11/6/2025) Novartis Wins China Approval for Two Plu... (11/6/2025) Dermavon Files for Hong Kong IPO to Adva... (11/6/2025) Suzhou Ribo Life Science Files for Hong ... (11/6/2025) BrightGene Advances Metabolic Drug Pipel... (11/6/2025)

China's Aging Population to Drive Trillion-Dollar Healt... China's Innovative Drug Market Shows Diverging Trends B... Innovent's Weight-Loss Drug Challenges Western Giants i... China's PD-(L)1 Market Shows Continued Growth in H1 202... China to Become World's Third-Largest Innovative Drug M...

Vigonvita Life Sciences Debuts on HKSE UniXell Secures CNY 100M in Series A+ Financing to Adv... BrightGene Advances Metabolic Drug Pipeline as It Files... Suzhou Ribo Life Science Files for Hong Kong IPO as siR... Dermavon Files for Hong Kong IPO to Advance Innovative ...

NMPA Pilots Streamlined Review Pathway for Supplemental... CDE Seeks Comments on the 100th Batch of Reference Form... CDE Invites Comments on the Draft Technical Guidelines ... NHSA Introduces New Measure to Strengthen Intelligent O... CDE Invites Comment on Implementation Guidance for ICH ...

China to Expand Use of Artificial Intelligence Across H... China Expands Drug Access Through 11th National Bulk-Bu... China to Include HPV Vaccines in National Immunization ... China's BMI Fund Maintains Strong Surplus in First Thre... China Adds Novel Drugs Catalog to National BMI Talks fo...

BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ... SAMR Orders Simcere to Reverse Unnotified Merger Over C...

Clariant Completes Expansion of Pharma Excipients and S... Sanofi Launches €1B Insulin API Manufacturing Project ... China Faces New Pressure as U.S. Eyes Middle East for D... FDA Issues Warning to Chengdu Biopharma Over cGMP Viola... China's Sharp API Price Cuts Jeopardize India's Self-Re...

Correctseq Reports World's First Gene-Editing Treatment... Sanofi's Cablivi Wins Approval in China as First Nanobo... CARsgen Reports Positive Results for Allogeneic CAR-T T... Lepu to Present Promising Phase II Data of CD20 ADC MRG... Novartis Wins China Approval for Two Pluvicto Indicatio...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Senior CSPC Executive Fined CNY 5M for Insider Trading Recent Executive Moves Recent Executive Moves Recent Official and Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...